RPS6KA1 and cancer: Since p90RSK is strongly activated in many human tumors [7], the use of specific drugs targeted to inhibit its kinase activity could represent a very important mechanism because the inhibition of p90RSK is able to stimulate, through the regulation of MDM2 and p53, the block of the proliferation and the promotion of apoptosis in cancer cells.